As an alternative outlet for keynote speakers and panel sessions we had planned for August 2020, University of Michigan will be teaming up with FASEB, the Federation of American Societies for Experimental Biology, is an international professional society founded in 1912 and representing over 130,000 researchers globally. FASEB BioAdvances is their international open-access journal. We are developing a special issue for November 2020 that will feature articles from #WNCD2020 who were to give keynote lectures and panel sessions as well as other invited thought leaders.
FASEB BioAdvances focuses on many topics relevant to noncommunicable diseases, such as physiology, genetics, nutrition, sports medicine, and clinical investigation. The aims and scope of FASEB BioAdvances aligns with the #WNCD2020 mission, aiming “to serve the global biology community by providing a vehicle for scientists to publish well-designed and executed research papers, regardless of perceived impact.” With an emphasis on multi/transdisciplinary research from the global scientific community, it is well-suited to the #WNCD2020 vision.
The special issue will include articles across each of the risk factors from the planned scientific program from WNCD2020. We believe that this publication plan will allow for us to reach a wider audience and provide opportunities to discuss each NCD risk factor in depth. We are happy to work with FASEB BioAdvances to guarantee this important scientific dialogue will continue.
In addition, we have completed our review of the 225 submitted abstracts. Of those 195 have been accepted and authors notified. We are working with our partner, the World NCD Federation, to publish the abstracts in their open access journal, the International Journal of Noncommunicable Diseases.